Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

13.630
-1.160-7.84%
Volume:8.39M
Turnover:112.44M
Market Cap:24.08B
PE:30.66
High:14.170
Open:14.170
Low:13.170
Close:14.790
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:0.67
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.445
ROE:12.77%
ROA:4.28%
PB:2.68
PE(LYR):30.66
PS:7.40

Loading ...

InnoCare Pharma (SEHK:9969) Is Up 6.6% After First CDH17 ADC Enters Human Trials

Simply Wall St.
·
Jul 14

Is InnoCare Pharma (SEHK:9969) Undervalued On Its Breakthrough Lupus Trial Results?

Simply Wall St.
·
Jul 11

Movement Alert|InnoCare Pharma Rises 5.07% in Regular Trading, HK Innovative Drug Sector Rallies as ADC Pipeline Advances

Market Focus
·
Jul 10

Innocare Pharma Shares Advance with Robust Quarterly Earnings Growth

Deep News
·
Jul 09

Hong Kong Market Closes Higher, Healthcare and Tech Stocks Lead Gains While AI Hardware Sector Plunges

Stock News
·
Jul 06

Biopharma Stocks Continue to Rally in Early Trading Session

Deep News
·
Jul 06

Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization

Stock News
·
Jul 06

Innocare's Stock Surges Over 9% as First Patient Dosed with Novel In-house Developed CDH17-Targeting ADC Drug

Deep News
·
Jul 06

Movement Alert|InnoCare Pharma Rises 6.65% in Regular Trading, Self-Developed ADC Drug ICP-B208 Completes First Patient Dosing

Market Focus
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

Innocare Shares Surge Over 8% Following First Patient Dosing of Novel In-House ADC Drug

Stock News
·
Jul 06

InnoCare issues 1.91 million RSUs under 2023 Share Award Scheme, equal to 0.11% of share capital

Bulletin Express
·
Jun 30

Innocare Pharma Issues 2.42 Million New Shares Under 2024 Equity Incentive Plan

Stock News
·
Jun 26

Extensive Orelabrutinib Data Across Regions Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)

Simply Wall St.
·
Jun 22

InnoCare Pharma (SEHK:9969) Stock Could Be 45% Undervalued After EHA 2026 Data

Simply Wall St.
·
Jun 21

Innocare Pharma Shares Surge Over 5% on Positive Phase III Data for Tafasitamab Combo in Frontline DLBCL

Stock News
·
Jun 18

INNOCARE Issues 8 Million Restricted Shares Under Incentive Plan

Stock News
·
Jun 16

InnoCare issues 8.00 million restricted shares (0.45% stake) in first tranche of 2026 RMB Share Incentive Scheme

Bulletin Express
·
Jun 16

InnoCare Pharma: Shareholders Overwhelmingly Approve All 24 Resolutions at 2026 AGM

Bulletin Express
·
Jun 16

Innovative Drug Stocks See Broad Gains as Sector's Outbound Licensing Activity Remains Robust, Supported by Policy Tailwinds and Commercialization Progress

Stock News
·
Jun 12